PRNewsWire
22 Sept 2026, 05:18 UTC · 1h ago
Verdict
Headline takes no side. We score HDB −1.00 across two claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish · 2 new · 0 priced in
Capricor Therapeutics is facing a class action lawsuit alleging it made false and misleading statements regarding the FDA approval progress of its drug candidate deramiocel.
Newpress release dated Sep 22, 2026
So whatLegal liabilities and potential settlements typically create a drag on EPS and can deter institutional investors until a resolution is reached.
More negative than 86% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
The lawsuit claims Capricor was aware of adverse data from its Phase 2 HOPE-2 trial while maintaining positive public comments during the class period of October 9, 2024, to July 10, 2025.
Newpress release dated Sep 22, 2026
So whatConfirmation of adverse Phase 2 data could lead analysts to downgrade the probability of success for the drug, lowering the company's discounted cash flow valuation.
More negative than 78% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is mentioned as being sued for securities law violations.
More negative than 96% of ticker scores this week
The company is facing a class action lawsuit for allegedly making false and misleading statements regarding its drug candidate's FDA approval process.
More negative than 96% of ticker scores this week
The company is mentioned as being sued for securities law violations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
7h ago
—
HDB hasn't traded since this ran. Last close $23.65 (Sep 21); the reaction starts at the next open.
HDB chart →